# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-059075
Filing Date
2021-04-30
Accepted
2021-04-30 16:28:33
Documents
4
Period of Report
2021-06-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2112813-1_def14a.htm | DEF 14A | 655758
2 | GRAPHIC | lg_liquidia-4c.jpg | GRAPHIC | 180948
3 | GRAPHIC | tm2112813d1-pc_pg01proxy4c.jpg | GRAPHIC | 1244974
4 | GRAPHIC | tm2112813d1-pc_pg02proxy4c.jpg | GRAPHIC | 895861
| Complete submission text file | 0001104659-21-059075.txt |  | 3850831

Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39724 | Film No.: 21878561
SIC: 2834 Pharmaceutical Preparations